• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氨基-3-羟基吡啶二氧代(吡啶-2,6-二羧基-κ³O²,N,O⁶)钒(V)的合成、晶体结构及其向纳米结构V₂O₅的转化

Synthesis and crystal structure of 2-amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-κ³O²,N,O⁶)vanadate(V) and its conversion to nanostructured V₂O₅.

作者信息

Hejrani-Dalir Ali, Tabatabaee Masumeh, Sheibani Ali

机构信息

Department of Chemistry, Yazd Branch, Islamic Azad University, Yazd, Iran.

出版信息

Acta Crystallogr C Struct Chem. 2015 Feb;71(Pt 2):89-92. doi: 10.1107/S2053229614027983. Epub 2015 Jan 12.

DOI:10.1107/S2053229614027983
PMID:25652272
Abstract

2-Amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-κ(3)O(2),N,O(6))vanadate(V), (C5H7N2O)[V(C7H3NO4)O2] or [H(amino-3-OH-py)][VO2(dipic)], (I), was prepared by the reaction of VCl3 with dipicolinic acid (dipicH2) and 2-amino-3-hydroxypyridine (amino-3-OH-py) in water. The compound was characterized by elemental analysis, IR spectroscopy and X-ray structure analysis, and consists of an anionic VO2(dipic) complex and an H(amino-3-OH-py)(+) counter-cation. The V(V) ion is five-coordinated by one O,N,O'-tridentate dipic dianionic ligand and by two oxide ligands. Thermal decomposition of (I) in the presence of polyethylene glycol led to the formation of nanoparticles of V2O5. Powder X-ray diffraction (PXRD) and scanning electron microscopy (SEM) were used to characterize the structure and morphology of the synthesized powder.

摘要

2-氨基-3-羟基吡啶双氧(吡啶-2,6-二羧基-κ(3)O(2),N,O(6))钒(V),(C5H7N2O)[V(C7H3NO4)O2] 或 [H(氨基-3-羟基吡啶)][VO2(吡啶-2,6-二甲酸)],(I),通过VCl3与吡啶-2,6-二甲酸(dipicH2)和2-氨基-3-羟基吡啶(氨基-3-羟基吡啶)在水中反应制备。该化合物通过元素分析、红外光谱和X射线结构分析进行表征,由阴离子VO2(吡啶-2,6-二甲酸)络合物和H(氨基-3-羟基吡啶)(+)抗衡阳离子组成。V(V)离子由一个O,N,O'-三齿吡啶-2,6-二甲酸二价阴离子配体和两个氧化物配体五配位。在聚乙二醇存在下(I)的热分解导致形成V2O5纳米颗粒。粉末X射线衍射(PXRD)和扫描电子显微镜(SEM)用于表征合成粉末的结构和形态。

相似文献

1
Synthesis and crystal structure of 2-amino-3-hydroxypyridinium dioxido(pyridine-2,6-dicarboxylato-κ³O²,N,O⁶)vanadate(V) and its conversion to nanostructured V₂O₅.2-氨基-3-羟基吡啶二氧代(吡啶-2,6-二羧基-κ³O²,N,O⁶)钒(V)的合成、晶体结构及其向纳米结构V₂O₅的转化
Acta Crystallogr C Struct Chem. 2015 Feb;71(Pt 2):89-92. doi: 10.1107/S2053229614027983. Epub 2015 Jan 12.
2
4-Hydroxypyridine-2,6-dicarboxylatodioxovanadate(V) complexes: solid state and aqueous chemistry.4-羟基吡啶-2,6-二羧基二氧钒(V)配合物:固态化学与水相化学
Inorg Chem. 2002 Dec 2;41(24):6322-31. doi: 10.1021/ic0201598.
3
Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.钒(III)(V(III))和V(III)-二吡啶甲酸盐体系的水相化学以及钒化合物三种氧化态对大鼠糖尿病高血糖影响的比较。
Inorg Chem. 2005 Jul 25;44(15):5416-27. doi: 10.1021/ic048331q.
4
Synthesis, characterization, X-ray crystal structure, DFT calculation and antibacterial activities of new vanadium(IV, V) complexes containing chelidamic acid and novel thiourea derivatives.含白屈氨酸和新型硫脲衍生物的新型钒(IV、V)配合物的合成、表征、X射线晶体结构、密度泛函理论计算及抗菌活性
J Inorg Biochem. 2015 Jun;147:54-64. doi: 10.1016/j.jinorgbio.2015.02.007. Epub 2015 Feb 20.
5
Vanadium complexes having [VO]2+, [VO]3+ and [VO2]+ cores with hydrazones of 2,6-diformyl-4-methylphenol: synthesis, characterization, reactivity, and catalytic potential.具有 [VO]2+、[VO]3+ 和 [VO2]+ 核的钒配合物与 2,6-二醛基-4-甲基苯酚的腙:合成、表征、反应性和催化潜力。
Dalton Trans. 2013 Sep 7;42(33):11941-62. doi: 10.1039/c3dt50469g.
6
Relationship between Antioxidant Activity and Ligand Basicity in the Dipicolinate Series of Oxovanadium(IV) and Dioxovanadium(V) Complexes.二齿酸根系列的氧钒(IV)和二氧钒(V)配合物的抗氧化活性与配体碱性之间的关系。
Int J Mol Sci. 2021 Sep 13;22(18):9886. doi: 10.3390/ijms22189886.
7
Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study.胃肠道介质中口服抗糖尿病钒配合物的反应活性-活性关系:一项X射线吸收光谱研究。
Metallomics. 2014 Oct;6(10):1880-8. doi: 10.1039/c4mt00146j. Epub 2014 Aug 6.
8
Kinetics and mechanistic studies of anticarcinogenic bisperoxovanadium(V) compounds: ligand substitution reactions at physiological pH and relevance to DNA interactions.抗癌双过氧钒(V)化合物的动力学和机理研究:生理pH下的配体取代反应及其与DNA相互作用的相关性
Inorg Chem. 2003 Dec 1;42(24):7967-77. doi: 10.1021/ic0350180.
9
Three novel organic-inorganic complexes based on decavanadate [V10O28]6- units: special water layers, open 3D frameworks and yellow/blue luminescences.三种基于十钒氧阴离子 [V10O28]6- 单元的新型有机-无机配合物:特殊的水分子层、开放的 3D 骨架和黄/蓝发光。
Dalton Trans. 2012 Jul 7;41(25):7737-45. doi: 10.1039/c2dt30532a. Epub 2012 May 24.
10
Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.合成和评价希夫碱缩合物的氧钒(IV)配合物来自 5-取代-2-羟基苯甲醛和 2-取代-苯甲胺作为蛋白酪氨酸磷酸酶 1B 的选择性抑制剂。
Dalton Trans. 2012 Aug 28;41(36):11116-24. doi: 10.1039/c2dt30198a.